Cargando…
Post COVID Interstitial Lung Abnormalities—Incidence and Management
PURPOSE OF REVIEW: This review aims to summarize the available literature to identify the incidence and risk factors for persistent interstitial lung abnormalities (ILAs) following hospitalization for COVID-19. The current and prospective treatment options are reviewed in an effort to help pulmonary...
Autores principales: | Robertshaw, Mark, Kershaw, Corey D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098239/ https://www.ncbi.nlm.nih.gov/pubmed/37206298 http://dx.doi.org/10.1007/s13665-023-00307-y |
Ejemplares similares
-
Persistent interstitial lung abnormalities in post-COVID-19 patients: a case series
por: Lago, Vanessa Carvalho, et al.
Publicado: (2021) -
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2022) -
Interstitial lung abnormalities – current knowledge and future directions
por: Axelsson, Gisli Thor, et al.
Publicado: (2021) -
Post-COVID Interstitial Lung Disease and Other Lung Sequelae
por: Barash, Mark, et al.
Publicado: (2023) -
Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)
por: Hino, Takuya, et al.
Publicado: (2021)